Hosted on MSN11mon
Encoded to launch Dravet syndrome gene therapy trial in US and AustraliaThis clearance allows Encoded to begin clinical trials of the gene therapy candidate designed to treat Sodium channel protein type 1 subunit alpha (SCN1A)+ Dravet syndrome. In addition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback